成人高血压的血压目标

Blood pressure targets in adults with hypertension

作者信息Doreen Y Larvie, Wade Thompson, Guillaume Grenet, James Wright, Ciprian Jauca, Douglas Salzwedel, Stephen Adams, Anshula Ambasta
PMID42861682
发布时间2026-10-12
DOI10.1002/14651858.CD016397

实验完整度

低

文献为Cochrane系统评价方案,未提供任何已完成的实验方法或验证结果

摘要

This is a protocol for a Cochrane review (intervention). The objectives are as follows: Primary objective To evaluate the benefits and harms of lower targets of blood pressure (BP; i.e. BP ≤ 135/85 mmHg) versus standard targets (i.e. BP ≤ 140 to 160/90 to 100 mmHg) for total mortality and morbidity in people 18 years or older, with elevated BP. Secondary objectives To evaluate the benefits and harms of lower targets versus standard targets for achieved systolic and diastolic BP in people 18 years or older, with elevated BP. To evaluate the benefits and harms of lower targets versus standard targets for withdrawals due to adverse events in people 18 years or older with elevated BP. To assess whether the effects of lower targets versus standard targets differ according to prespecified equity-related characteristics (e.g. place of residence, race/ethnicity/culture/ancestry, sex, socioeconomic status, and social capital, plus other context-specific factors, including comorbidity burden) in people 18 years or older, with elevated BP.

实验结论

提炼研究问题、关键发现与证据,快速把握文章的核心贡献。

研究问题
评估成人高血压患者较低血压目标(≤135/85 mmHg)与标准目标(≤140-160/90-100 mmHg)在总死亡率和发病率方面的获益与危害。
核心机制
文中未明确说明
主要证据
文中未明确说明
研究意义
文中未明确说明

研究方法

按研究目的归类文中使用的方法,便于定位所需技术。

产品清单

实验环节名称品牌货号
CovidenceVeritas Health Innovation--
Review Manager (RevMan)The Cochrane Collaboration--
Microsoft Excel----